In this large-scale prospective cohort study, observational analysis found that each increase in plasma cystatin C concentration was associated with 9% higher risks of CVD events, 14% higher risks of CVD mortality, 10% higher risks of stroke, and 8% higher risks of MI. Here, CST3 is linked to stroke disorder.